Akebia Therapeutics Inc (AKBA)
EBITDA Growth
-170.06%
Quarterly · Period ending:
AKBA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-170.06%period ending
Latest reported-170.06%period ending
AKBA Quarterly EBITDA YoY % (-47.26% → -170.06%)
Year-over-year change
High-resolution chart · PNG
AKBA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -170.0554% | |
| -193.625% | |
| 7.5205% | |
| 255.3696% | |
| 524.2194% | |
| 388.9477% | |
| -157.5551% | |
| -9.0414% | |
| 1,063.4146% | |
| 69.1123% | |
| -33.4962% | |
| 90.9823% | |
| -100.2801% | |
| 66.8148% | |
| 135.8526% | |
| 9.4608% | |
| 164.0425% | |
| 13.2486% | |
| -0.9811% | |
| 11.926% | |
| 58.1454% | |
| -12.413% | |
| 27.1753% | |
| -10.6237% | |
| -232.1951% | |
| 25.1207% | |
| 24.7522% | |
| -67.141% | |
| -39.1193% | |
| -170.1305% | |
| -849.5244% | |
| -15.0319% | |
| -60.9955% | |
| 45.8059% | |
| 130.4958% | |
| 33.471% | |
| 39.0792% | |
| -72.3572% | |
| -89.231% | |
| -83.7194% | |
| -232.8606% | |
| -141.3844% | |
| -96.6343% | |
| -105.2346% | |
| -38.7072% | |
| -12.5263% | |
| -273.2517% | |
| -137.2588% | |
| -271.6866% | |
| -47.2603% |